e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Diagnostic and therapeutic approaches in pleural diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relationship between survival after talc pleurodesis and classic prognostic factors in pleural metastatic breast carcinoma
A. Romero Falcon, A. Montes Worboys, J. L. Lopez-Campos Bodineau, A. Casas Fernandez de Tejerina, F. Rodriguez Panadero (Sevilla, Spain)
Source:
Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Session:
Diagnostic and therapeutic approaches in pleural diseases
Session type:
Thematic Poster Session
Number:
671
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Romero Falcon, A. Montes Worboys, J. L. Lopez-Campos Bodineau, A. Casas Fernandez de Tejerina, F. Rodriguez Panadero (Sevilla, Spain). Relationship between survival after talc pleurodesis and classic prognostic factors in pleural metastatic breast carcinoma. Eur Respir J 2008; 32: Suppl. 52, 671
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Massive pleural effusion presented with a very rare multitude of complication
Related content which might interest you:
Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients
Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Year: 2009
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011
Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005
Therapeutic outcome and prognostic factors in patients with pleural mesothelioma
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005
Survival and clinico-pathologic prognostic factors in surgically resected non-small cell lung carcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006
Prognostic factors in diffuse malignant pleural mesothelioma
Source: Eur Respir J 2007; 30: Suppl. 51, 755s
Year: 2007
Prognostic factors in diffuse malignant pleural mesothelioma
Source: Eur Respir J 2003; 22: Suppl. 45, 62s
Year: 2003
Clinical and morphological prognostic factors in patients with malignant pleura mesothelioma (MPM)
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010
Biochemical and cytological features of metastatic pleural effusions in breast cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 671s
Year: 2007
Talc chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 509s
Year: 2003
Ultra-late pleural metastasis of breast cancer: are they so rare?
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021
Prognostic factors and surgical resection of pulmonary metastases from colorectal cancer
Source: International Congress 2019 – General thoracic surgery
Year: 2019
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006
Prognostic value of treatment outcomes patients with malignant pleural mesothelioma
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010
Is comorbidity a good prognostic factor for malignant pleural mesothelioma?
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Factors affecting the prognosis of nonsmall cell lung cancer with chest wall-parietal pleural invasion (T3) following resection
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
Clinicopathological prognostic factors in operated for lung cancer and brain metastasis patients
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Prognostic characteristics of malignant pleural mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
The analysis of clinicopathological characteristics and prognosis of malignant pleural mesothelioma
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma?
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept